Net worth predicts symptom burden at the end of life.

TitleNet worth predicts symptom burden at the end of life.
Publication TypeJournal Article
Year of Publication2005
AuthorsSilveira, MJ, Kabeto, MU, Langa, KM
JournalJ Palliat Med
Volume8
Issue4
Pagination827-37
Date Published2005 Aug
ISSN Number1096-6218
Call Numberpubs_2005_Silviera.pdf
KeywordsAged, Aged, 80 and over, Data collection, Female, Humans, Logistic Models, Male, Severity of Illness Index, Social Class, Terminally Ill, United States
Abstract

OBJECTIVES: To explore the predictors of symptom burden at the end of life.

DESIGN: Observational, secondary analysis of Health and Retirement Study (HRS) data.

SETTING: USA.

PARTICIPANTS: Two thousand six hundred four deceased, older adults.

METHODS: Multivariate Poisson and logistic regression to explore the relationship between sociodemographic and clinical factors with symptoms.

RESULTS: Fatigue, pain, dyspnea, depression, and anorexia were common and severe; 58% of participants experienced more than 3 of these during their last year of life. Sociodemographic and clinical factors were associated with the number of symptoms as well as the presence of pain, depression, and dyspnea alone. Decedents in the highest quartile of net worth had fewer symptoms (incident rate ratio [IRR] 0.90, confidence interval [CI] 0.85-0.96) and less pain (odds ratio [OR] 0.66, CI 0.51-0.85) than comparisons did. Patients with cancer experienced more pain (OR 2.02, CI 1.62-2.53) and depression (OR 1.31, CI 1.07-1.61). Patients experienced more depression (OR 2.37, CI 1.85-3.03) and dyspnea (OR 1.40, CI 1.09-1.78).

LIMITATION: Use of proxy reports for primary data.

CONCLUSION: Older Americans experience a large symptom burden in the last year of life, largely with treatable symptoms such as pain, dyspnea, and depression. The adequacy of symptom control relates to clinical factors as well as net worth. This association between symptoms and wealth suggests that access to health care and other social services beyond those covered by Medicare may be important in decreasing symptom burden at the end of life.

DOI10.1089/jpm.2005.8.827
User Guide Notes

http://www.ncbi.nlm.nih.gov/pubmed/16128657?dopt=Abstract

Endnote Keywords

Quality of Life/Net Worth

Endnote ID

13892

Alternate JournalJ Palliat Med
Citation Key7010
PubMed ID16128657
Grant ListU01 AG009740 / AG / NIA NIH HHS / United States
K08 AG 19180 / AG / NIA NIH HHS / United States
U01 AG 09740 / AG / NIA NIH HHS / United States